BAFNAPH — BAFNA Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹10.69bn
- IN₹11.03bn
- IN₹1.51bn
Annual cashflow statement for BAFNA Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 51.9 | 118 | 73.5 | 41.5 | 110 |
| Depreciation | |||||
| Non-Cash Items | 15.7 | 16.2 | 30.3 | 52.1 | 38.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -25.3 | -138 | -58.9 | 78.8 | -55.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 97.3 | 49.5 | 94.8 | 221 | 154 |
| Capital Expenditures | -75.4 | -82.2 | -158 | -219 | -249 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 9.97 | 7.26 | 7.95 | 6.97 | 25 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -65.4 | -74.9 | -151 | -212 | -224 |
| Financing Cash Flow Items | -0.882 | -16.9 | -23.1 | -27.5 | -36.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -48.1 | 102 | -8.45 | 10.6 | 56.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -16.3 | 76.4 | -64.1 | 20.4 | -14.1 |